Replies to post #17813 on COSCIENS Biopharma Inc (CSCI)

[livendi]

well worth the wait if approved because eu and row will follow fda approval and thats just 1 use for macrilen,even if fda approves 1 of the other uses for macrilen,either cancer cachexia or tbi,what will sales of macrilen balloon 2,long term play here but it could jump short term 2 especially with covid pill vaccine trials and other precliclincals aezs working on,god bless all